TY - JOUR
T1 - Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm
AU - Garcia-Olivé, Ignasi
AU - Sanz-Santos, Jose
AU - Centeno, Carmen
AU - Andreo, Felipe
AU - Muñoz-Ferrer, Aida
AU - Serra, Pere
AU - Sampere, Jaume
AU - Michavila, Josep Maria
AU - Muchart, Jordi
AU - Manzano, Juan Ruiz
PY - 2014/2/1
Y1 - 2014/2/1
N2 - Purpose To describe experience with bronchial artery embolization (BAE) in a cohort of patients with cancer. Materials and Methods All consecutive patients with cancer and at least one episode of hemoptysis that required BAE during a 14-year period were included in this observational retrospective review. The endpoints of the study were immediate success, recurrence of hemoptysis, mortality resulting from hemoptysis, and all-cause mortality. Results Immediate control of bleeding was achieved in 31 of 40 patients (77.5%). Recurrence requiring BAE occurred in eight patients (20%). Cumulative hemoptysis control rate was 0.90 (95% confidence interval [CI], 0.80-1.0) at 1 month and 0.65 (95% CI, 0.44-0.86) at 6 months. Probability of survival was 0.75 (95% CI, 0.62-0.88) at 1 month, 0.42 (95% CI, 0.27-0.57) at 6 months, 0.36 (95% CI, 0.21-0.51) at 12 months, and 0.08 (95% CI, 0.0-0.18) at 3 years. Conclusions BAE is an effective and safe technique in the treatment of hemoptysis in patients with cancer. Nevertheless, mortality resulting from hemoptysis and recurrence rate are high among these patients secondary to progression of the underlying disease. © 2014 SIR.
AB - Purpose To describe experience with bronchial artery embolization (BAE) in a cohort of patients with cancer. Materials and Methods All consecutive patients with cancer and at least one episode of hemoptysis that required BAE during a 14-year period were included in this observational retrospective review. The endpoints of the study were immediate success, recurrence of hemoptysis, mortality resulting from hemoptysis, and all-cause mortality. Results Immediate control of bleeding was achieved in 31 of 40 patients (77.5%). Recurrence requiring BAE occurred in eight patients (20%). Cumulative hemoptysis control rate was 0.90 (95% confidence interval [CI], 0.80-1.0) at 1 month and 0.65 (95% CI, 0.44-0.86) at 6 months. Probability of survival was 0.75 (95% CI, 0.62-0.88) at 1 month, 0.42 (95% CI, 0.27-0.57) at 6 months, 0.36 (95% CI, 0.21-0.51) at 12 months, and 0.08 (95% CI, 0.0-0.18) at 3 years. Conclusions BAE is an effective and safe technique in the treatment of hemoptysis in patients with cancer. Nevertheless, mortality resulting from hemoptysis and recurrence rate are high among these patients secondary to progression of the underlying disease. © 2014 SIR.
U2 - 10.1016/j.jvir.2013.09.017
DO - 10.1016/j.jvir.2013.09.017
M3 - Article
VL - 25
SP - 221
EP - 228
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
SN - 1051-0443
IS - 2
ER -
